Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice
Clinical trial NCT05112835 · TERMINATED
Trial details
- NCT number
- NCT05112835
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-19
- Primary completion
- 2022-09-08
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.